N P Shah - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

N P Shah

Showing results (81-90 of 84) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 84 results.

Public Health Action|November 15, 2021

High success and low recurrence with shorter treatment regimen for multidrug-resistant TB in NepalS Koirala, N P Shah, P Pyakurel, et al.

Tuberculosis (Edinburgh, Scotland)|October 29, 2005

Bovine tuberculosis in India: potential basis for zoonosisH K Prasad, A Singhal, A Mishra, et al.

Leukemia|April 11, 2008

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinibA Hochhaus, M Baccarani, M Deininger, et al.

The New England Journal of Medicine|November 5, 2013

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemiasJ E Cortes, D-W Kim, J Pinilla-Ibarz, et al.

Pageof 9

Search research articles

Showing results (81-90 of 84) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 84 results.

Public Health Action|November 15, 2021

High success and low recurrence with shorter treatment regimen for multidrug-resistant TB in NepalS Koirala, N P Shah, P Pyakurel, et al.

Tuberculosis (Edinburgh, Scotland)|October 29, 2005

Bovine tuberculosis in India: potential basis for zoonosisH K Prasad, A Singhal, A Mishra, et al.

Leukemia|April 11, 2008

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinibA Hochhaus, M Baccarani, M Deininger, et al.

The New England Journal of Medicine|November 5, 2013

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemiasJ E Cortes, D-W Kim, J Pinilla-Ibarz, et al.

Pageof 9